Skip to main content

NeuroPace Inc

NPCE
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001528287

No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding NeuroPace Inc changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of NPCE: Q3 2023 compared with Q4 2023
MeasureQ3 2023Of which not filed for Q4 2023Q4 2023Change
Holders25141+17
Shares18.1M5.62M12.7M+237.4K (+1.9%)
Value$175.9M$54.7M$130.8M+$9.67M (+8.0%)

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (18)

Institutions that held NeuroPace Inc at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to NPCE in Q4 2023
InstitutionSharesValue% of portfolio
Susquehanna International Group, LLP42,285$436.0K0.00%
Jane Street Group, LLC36,822$379.6K0.00%
Balyasny Asset Management LLC27,156$280.0K0.00%
683 Capital Management, LLC24,933$257.1K0.03%
Citadel Advisors LLC24,055$248.0K0.00%
Laurion Capital Management LP20,699$213.4K0.01%
ExodusPoint Capital Management, LP19,791$204.0K0.00%
Man Group plc19,298$199.0K0.00%
TownSquare Capital, LLC15,859$163.5K0.00%
Walleye Capital LLC14,320$147.6K0.00%
Marshall Wace, LLP14,171$146.1K0.00%
Cubist Systematic Strategies, LLC11,415$117.7K0.00%
JPMorgan Chase & Co11,360$117.1K0.00%
Virtu Financial LLC10,764$111.0K0.01%
Lazard Asset Management LLC3,929$40.0K0.00%
Point72 Asia (Singapore) Pte. Ltd.257$2.65K0.00%
Tower Research Capital LLC (TRC)252$2.60K0.00%
Advisor Group Holdings, Inc.233$2.40K0.00%

Sold out (1)

Institutions that held NeuroPace Inc at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of NPCE in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
UBS Group AG55$535

Not filed for Q4 2023 yet (1)

Institutions that held NeuroPace Inc at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding NPCE in Q3 2023 that haven't filed for Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
KCK Ltd.5,621,111$54.7M